ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,093.94
0.54%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Anthera Pharmaceuticals Inc (CE) (ANTH)

  7. Anthera Pharmaceuticals Inc (CE) (ANTH) News

Anthera Pharmaceuticals (CE) (ANTH)

Anthera Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ANTH
DateTimeSourceHeadlineSymbolCompany
12/09/201820:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
30/07/201821:45Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201811:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:28Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:23Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:22Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:21Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201821:06Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
17/07/201819:38Edgar (US Regulatory)(25)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
09/07/201822:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/06/201821:14Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/06/201813:00GlobeNewswire Inc.Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
18/06/201821:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ANTH

Your Recent History

LSE
ZED
Zenova
LSE
KEFI
Kefi Gold And Copper
LSE
CHLL
Chill Brands
LSE
GKP
Gulf Keystone Petroleum
LSE
SAR
Sareum
LSE
KRS
Keras Resources
LSE
POS
Plexus
LSE
GOLD
LSE
LLOY
Lloyds Banking
LSE
VOD
Vodafone
LSE
AVCT
Avacta
LSE
VAST
Vast Resources
LSE
RKH
Rockhopper Exploration
LSE
GDR
Genedrive
LSE
TERN
Tern
LSE
AGL
Angle
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved